The forecast for the import of insulin in dosage forms to Italy shows a gradual decline from 2024 to 2028, with values starting at 152.0 million USD in 2024 and decreasing to 137.72 million USD by 2028. This indicates a steady year-on-year decrease. In 2023, these imports stood at an unspecified value, reflecting an overall downward trend continuing into the forecast period. The year-on-year percentage variations depict a consistent decrease, and the Compound Annual Growth Rate (CAGR) suggests an average decline over the five-year forecast period.

Future trends to watch for include:

Potential shifts in domestic insulin production capabilities in Italy, potentially influencing import levels.
Changes in global insulin market dynamics, affecting supply chain and pricing.
Healthcare policy changes in Italy that could impact insulin usage and import demand.